BBLG
Bone Biologics CorpCompany Information
- Company Name
- Bone Biologics Corp
- CIK
- CIK0001419554
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- BBLG: Nasdaq, BBLGW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3842
- SIC Description
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Ticker
- BBLG
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-09-13
- Last sale
- —
- Shares purchased (TTM)
- 32,100
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 26,062
- Shares outstanding
- 1,796,755
- Ownership
- 1.45%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -13.28%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | 4 | 5 | 5 | 6 | 7 | 3 | 3 | 4 | 2 | 3 | 3 | 4 | ||||||
| Interest Receivable | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Assets Current | 4 | 5 | 6 | 6 | 7 | 3 | 4 | 4 | 3 | 4 | 4 | - | ||||||
| Assets | 4 | 5 | 6 | 6 | 7 | 3 | 4 | 4 | 3 | 4 | 4 | 5 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Liabilities Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Liabilities | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 94 | 94 | 94 | 93 | 93 | 89 | 89 | 87 | 85 | 85 | 84 | 83 | ||||||
| Retained Earnings Accumulated Deficit | -90 | -89 | -88 | -87 | -87 | -86 | -85 | -83 | -83 | -82 | -81 | -79 | ||||||
| Stockholders Equity | 4 | 5 | 5 | 6 | 7 | 3 | 3 | 4 | 3 | 4 | 3 | 4 | ||||||
| Liabilities And Stockholders Equity | 4 | 5 | 6 | 6 | 7 | 3 | 4 | 4 | 3 | 4 | 4 | 5 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 2 | 2 | 2 | 2 | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 2 | 2 | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBone Biologics Corp (BBLG) — SEC Financial Statements & Analysis
Bone Biologics Corp (BBLG) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. Bone Biologics Corp trades on Nasdaq as: BBLG, BBLGW. Bone Biologics Corp (BBLG)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Bone Biologics Corp carries a market cap of $2.46M, a P/E ratio of -0.85x, a P/B ratio of 0.63x, an enterprise value of $-1.57M, and an EV/EBITDA multiple of 0.51x. On profitability, it posts a Return on Equity (ROE) of -54.96%, a Return on Assets (ROA) of -50.55%, and a Return on Invested Capital (ROIC) of -1973.21%. Per share, it reports EPS of $-1.61, diluted EPS of $-1.61, free cash flow per share of $-1.46, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -31.50% year-over-year and EPS growth of -78.73% year-over-year. On the balance sheet, it maintains a current ratio of 8.67x, a quick ratio of 8.65x, working capital of $3.92M, a debt-to-equity ratio of 0.13x, a debt ratio of 0.12, an interest coverage ratio of -16545.73x, free cash flow of $-2.63M (TTM), and net debt of $-4.03M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.46M
- P/E TTM
- -0.85x
- EPS TTM
- $-1.61
- P/B TTM
- 0.63x
- ROE TTM
- -54.96%
- ROA TTM
- -50.55%
- Debt To Equity
- 0.13x
- Free Cash Flow TTM
- $-2.63M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Bone Biologics Corp in?
Bone Biologics Corp (BBLG) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.
What exchange does BBLG trade on?
Bone Biologics Corp (BBLG) trades on the Nasdaq.
Where is Bone Biologics Corp incorporated?
Bone Biologics Corp is incorporated in DE.
When was Bone Biologics Corp (BBLG)'s most recent SEC filing?
Bone Biologics Corp (BBLG)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is BBLG's market cap?
Bone Biologics Corp (BBLG) has a market capitalization of $2.46M as of 2026-06-30.
What is BBLG's EPS (earnings per share)?
Bone Biologics Corp (BBLG)'s trailing twelve month EPS is $-1.61 as of 2026-06-30.
What is BBLG's ROE (return on equity)?
Bone Biologics Corp (BBLG)'s trailing twelve month Return on Equity (ROE) is -54.96% as of 2026-06-30.
What is BBLG's ROA (return on assets)?
Bone Biologics Corp (BBLG)'s trailing twelve month Return on Assets (ROA) is -50.55% as of 2026-06-30.
What is BBLG's ROIC (return on invested capital)?
Bone Biologics Corp (BBLG)'s trailing twelve month Return on Invested Capital (ROIC) is -1973.21% as of 2026-03-31.
What is BBLG's EV/EBITDA?
Bone Biologics Corp (BBLG)'s trailing twelve month EV/EBITDA is 0.51x as of 2026-06-30.